Supernus Pharmaceuticals, Inc. (0LB2.L) LSE

51.80

+0(+0.00%)

Updated at December 24 02:50PM

Currency In USD

Valuation

Market Cap1.99B
Enterprise Value1.96B
P/E Ratio-153.15
PEG Ratio1.19
Price/Sales Ratio0.02
Price/Book Ratio0
Enterprise/Revenue-0.61
Enterprise/EBITDA-2,719.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0
Operating Margin-0.31

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue661.82M
Revenue/Share3,405.54
Gross Profit583.91M
EBITDA178.28M
Net Income73.86M
Diluted EPS1.32

Balance Sheet

Total Cash281.16M
Total Cash/Share4,971.64
Total Debt31.42M
Total Debt/Equity0.03
Current Ratio1.8
Book Value Per Share18,560.85

Price History

52-Week Change42.07
52-Week High51.8
52-Week Low22.54
Moving Average 50 Days27.93
Moving Average 200 Days29.84

Statistics

Average Volume83
Shares Outstanding55.97M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A